Skip to main content

Table 1 Demographics and transplant characteristics, mean (SD), at baseline (8 weeks − 1 year after renal transplantation) -

From: Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score

Variables

Paricalcitol N = 37

Paricalcitol N = 37

No treatment N = 39

No treatment N = 39

Time point post Tx

8 weeks

1 year

8 weeks

1 year

Age (years)

56.0 (13.4)

NA

54.2 (12.1)

NA

Albumin (g/L)

42.4 (2.4)

43.3 (2.5)

41.7 (2.5)

43.3 (2.7)

ALP (U/L)

61.4 (21.7)

58.4 (20.5)

70.2 (28.0)

71.4 (33.4)

BMI (kg/m2)

26.1 (3.2)

NA

25.5 (3.9)

NA

Calcium, total (mmol/L)

2.4 (0.1)

2.4 (0.1)

2.4 (0.1)

2.4 (0.1)

Creatinine (μmol/L)

114.4(24.5)

110.3 (26.7)

120.9 (29.6)

114.6 (27.5)

Phosphate (mmol/L)

0.9 (0.2)

0.9 (0.1)

0.9 (0.3)

0.9 (0.1)

PTH (pmol/L)

11.5 (5.7)

7.9 (4.8)

11.4 (5.3)

9.9 (3.8)

T50 (min)

311 (35)

319 (34.5)

319 (34)

323 (35.6)

HLA mismatch

3.1 (1.3)

NA

3.0 (1.4)

NA

Gender (% male)

27 (73)

NA

33 (84.6)

NA

Smoking (% Yes)

5 (13.5)

NA

5 (12.8)

NA

Living donor (% Yes)

10 (27.0)

NA

13 (33.3)

NA

Predialytic transplantation (% Yes)

13 (31.1)

NA

12 (30.8)

NA

Pretransplant diabetes (% Yes)

7 (18.9)

NA

6 (15.4)

NA

  1. NA denotes not available. For clarity all figures are reported to two decimals
  2. Abbreviations: ALP alkaline phosphatase, BMI body mass index, PTH parathyroid hormone, T50; time to 50% transfer to crystalline particles, HLA human leukocyte antigen